Picato

DRUG2 trials

Sponsors

LEO Pharma, Center for Clinical Studies, Texas

Conditions

Anogenital WartsMolluscum Contagiosum

Early Phase 1

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

WithdrawnNCT03336372

Center for Clinical Studies, TexasMolluscum Contagiosum

Start: 2017-12-20End: 2018-10-16Updated: 2022-04-01

Phase 2

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

CompletedNCT02377999

LEO PharmaAnogenital Warts

Start: 2015-02-28End: 2015-11-30Updated: 2025-02-24